Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Dose Finding, Pharmacokinetic and Safety Study of a Recombinant Human Plasminogen Activator (HTU-PA) in Patients With Acute Ischemic Stroke

NCT00418275 is registered in ClinicalTrials.gov with Global Biotech as lead sponsor.

NCT NCT00418275
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00418275 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Dose Finding, Pharmacokinetic and Safety Study of a Recombinant Human Plasminogen Activator (HTU-PA) in Patients With Acute Ischemic Stroke
Lead sponsor
Global Biotech
Phase
Phase 1/2
Overall status
Completed
Start date
April 30, 2001
Completion date
June 30, 2004
Enrollment
30
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cerebrovascular accident